You are here

Novartis

Analysts Expect Novartis’s Revenues to Remain Flat in 1Q17

Market Realist

Sat, 04/22/17 - 01:21 pm

Novartis Tests New Alzheimer's Drugs on People Who Don't Have the Disease

FOX Business

Sat, 04/22/17 - 01:12 pm

Alzheimer's disease

Black box warning? No worries, Valeant bills Siliq as the ‘low-cost’ psoriasis alternative to rivals from Novartis, Eli Lilly

Endpoints

Fri, 04/21/17 - 11:45 am

Valeant Pharmaceuticals

China pharma poised for explosive growth, Novartis CEO says

Fierce Pharma

Wed, 04/19/17 - 04:16 pm

Allergan, Novartis ink NASH partnership

BioPharma Dive

Wed, 04/19/17 - 10:02 am

Hey Pfizer, Novartis and Eli Lilly. G1 Therapeutics says it can beat all of you in its $115M IPO

Endpoints

Tue, 04/18/17 - 08:58 pm

G1 Therapeutics

Novartis Snags Coveted FDA 'Breakthrough' Label for CAR-T, Trial Results Still Under Wraps

TheStreet.com

Tue, 04/18/17 - 09:49 am

breakthrough status

When do pharmas disclose launch prices up front? When they’re pricing at a discount

Fierce Pharma

Fri, 04/14/17 - 10:03 am

Novartis' Gilenya patent loss sets MS market up for battle with early generics

Fierce Pharma

Thu, 04/13/17 - 06:49 pm

multiple sclerosis

3 Big Pharma Companies With the Best Pipelines

Motley Fool

Sun, 04/9/17 - 12:24 pm

Novartis Keeps 'JULIET' Study Results Close as Investors and Rival Kite Pharma Wait

TheStreet.com

Fri, 04/7/17 - 09:45 am

diffuse large B-cell lymphoma

Tiny Mass. biotech strikes licensing deal with Novartis worth up to $1B

Bizjournals.com

Thu, 04/6/17 - 11:58 pm

dry eye disease

Novartis' targeted meds Tafinlar, Mekinist pick up EU combo approval in lung cancer

Fierce Pharma

Wed, 04/5/17 - 12:07 pm

Rivals multiplying, Pfizer appeals to doctor preferences with Ibrance's latest label win

Fierce Pharma

Tue, 04/4/17 - 10:58 pm

HER-2 negative breast cancer

Investigational Breast Cancer Drug Could Boost Novartis’s Position

Marketwatch

Mon, 04/3/17 - 11:52 am

Novartis' Lung Cancer Drug Combo Gets EU Nod

Investopedia

Mon, 04/3/17 - 09:19 am

metastatic non-small cell lung cancer

How Novartis Is Aiming to Increase Entresto Sales in 2017

Market Realist

Fri, 03/31/17 - 10:06 am

Kickbacks judge to Novartis: Hand over the info on those 79,000 'sham' events

Fierce Pharma

Thu, 03/30/17 - 06:34 pm

What Could Boost Medicare Demand for Novartis’s Entresto?

Market Realist

Thu, 03/30/17 - 10:55 am

Novartis Makes Plans For Its Cancer-Killing T Cells

Forbes

Wed, 03/29/17 - 10:35 pm

Pages